HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karuppiah Muthumani Selected Research

3-phenyl-4,5-dihydro-5-isoxazole acetic acid

3/2016Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects.
8/2014VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karuppiah Muthumani Research Topics

Disease

14Infections
01/2017 - 10/2002
3Rheumatoid Arthritis
03/2016 - 08/2011
3Communicable Diseases (Infectious Diseases)
01/2016 - 01/2003
3Neoplasms (Cancer)
01/2009 - 10/2004
2Virus Diseases (Viral Diseases)
01/2016 - 12/2008
2Hypoxia (Hypoxemia)
01/2015 - 03/2014
2HIV Infections (HIV Infection)
03/2009 - 03/2004
2Melanoma (Melanoma, Malignant)
01/2009 - 11/2006
2Inflammation (Inflammations)
12/2002 - 01/2002
1Pneumonia (Pneumonitis)
01/2017
1Human Influenza (Influenza)
01/2017
1Emerging Communicable Diseases (Emerging Infectious Diseases)
01/2016
1Zika Virus Infection
01/2016
1Weight Loss (Weight Reduction)
01/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2014
1Pleurisy (Pleuritis)
08/2014
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2014
1Autoimmune Diseases (Autoimmune Disease)
08/2014
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2014
1Chronic Limb-Threatening Ischemia
03/2014
1Necrosis
03/2014
1Ischemia
03/2014
1Congenital Abnormalities (Deformity)
11/2012
1Joint Diseases (Joint Disease)
08/2011
1Arthritis (Polyarthritis)
08/2011
1Bacterial Infections (Bacterial Infection)
07/2010

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2015 - 03/2004
5VaccinesIBA
01/2017 - 01/2003
4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2006
4DNA VaccinesIBA
01/2016 - 01/2003
3vpr Gene ProductsIBA
03/2009 - 11/2006
23-phenyl-4,5-dihydro-5-isoxazole acetic acidIBA
03/2016 - 08/2014
2A-Form DNA (A-DNA)IBA
01/2016 - 11/2006
2Antiviral Agents (Antivirals)IBA
08/2015 - 03/2004
2Amino AcidsFDA Link
10/2013 - 01/2009
2Peptides (Polypeptides)IBA
10/2013 - 01/2009
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2011 - 03/2004
2AntigensIBA
12/2008 - 01/2002
2Caspase 9IBA
12/2002 - 10/2002
1Formaldehyde (Formol)FDA Link
01/2017
1NucleoproteinsIBA
01/2017
1Respiratory Syncytial Virus VaccinesIBA
01/2017
1InterferonsIBA
01/2016
1Toll-Like Receptor 4IBA
08/2014
1OligonucleotidesIBA
08/2014
1Acetic Acid (Vinegar)FDA LinkGeneric
08/2014
1LipopolysaccharidesIBA
08/2014
1Hematoxylin (Haematoxylon)IBA
03/2014
1Eosine Yellowish-(YS) (Eosin)IBA
03/2014
1Transcription Factors (Transcription Factor)IBA
03/2014
1AntibodiesIBA
03/2014
1HLA-DQB1 antigen (HLA DQB1)IBA
10/2013
1EnzymesIBA
09/2011
1Nucleocapsid ProteinsIBA
09/2011
1ChemokinesIBA
08/2011
1Interleukin-6 (Interleukin 6)IBA
08/2011
1CytokinesIBA
08/2011
1Interleukin-8 (Interleukin 8)IBA
08/2011
1Interleukin-10 (Interleukin 10)IBA
08/2011
1Indicators and Reagents (Reagents)IBA
01/2009
1Viral ProteinsIBA
04/2004
1p38 Mitogen-Activated Protein KinasesIBA
03/2004
1MitogensIBA
03/2004
1Phosphotransferases (Kinase)IBA
03/2004
1Annexin A5IBA
03/2004
1phosphatidylglucosaminylglycerolIBA
01/2003
1Caspase 8 (Caspase-8)IBA
10/2002

Therapy/Procedure

5Therapeutics
01/2016 - 10/2004
1Lasers (Laser)
03/2014
1Organ Transplantation
11/2012